Biodefense Market Size By Product (Vaccines {Anthrax, Smallpox, Botulism}, Biothreat Detection Devices {Samplers, Detectors/Triggering Devices, Identifiers, Assays And Reagents}), Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2018 – 2024

Published Date: Jan 2019  |  Report ID: GMI714  |  Authors: Sumant Ugalmugle

Report Format: PDF   |   Pages: 115   |   Base Year: 2017




Report Content

Chapter 1. Methodology

1.1. Methodology

1.2. Market definitions

1.3. Forecast parameters

1.4. Data sources

1.4.1.  Secondary

1.4.1.1. Paid sources

1.4.1.2. Unpaid sources

1.4.2.  Primary

Chapter 2. Executive Summary

2.1. Biodefense industry 3600 synopsis, 2013 - 2024

2.1.1.  Business trends

2.1.2.  Product trends

2.1.3.  Regional trends

Chapter 3. Biodefense Industry Insights

3.1. Industry segmentation

3.2. Industry landscape, 2013 - 2024

3.3. Industry impact forces

3.3.1.  Growth drivers

3.3.1.1.  Growing investments by government in R&D in North America & Europe

3.3.1.2.  Favorable government initiatives in Asia Pacific and Latin America

3.3.1.3.  Technological advancements in biotechnology sector in North America and Europe

3.3.2.  Industry pitfalls and challenges

3.3.2.1.  Low R&D funding by government in underdeveloped regions

3.4. Growth potential analysis

3.4.1.  By product

3.5. Competitive landscape, 2017

3.5.1.  Strategy dashboard

3.6. Porter’s analysis

3.7. PESTEL analysis

Chapter 4. Biodefense Market, By Product

4.1. Key segment trends

4.2. Vaccines

4.2.1.  Market size, by region, 2013-2024 (USD Million)

4.2.2.  Anthrax

4.2.2.1.    Market size, by region, 2013-2024 (USD Million)

4.2.3.  Smallpox

4.2.3.1.    Market size, by region, 2013-2024 (USD Million)

4.2.4.  Botulism

4.2.4.1.    Market size, by region, 2013-2024 (USD Million)

4.2.5.  Others

4.2.5.1.    Market size, by region, 2013-2024 (USD Million)

4.3. Biothreat detection devices

4.3.1.  Market size, by region, 2013-2024 (USD Million)

4.3.2.  Samplers

4.3.2.1.    Market size, by region, 2013-2024 (USD Million)

4.3.3.  Detectors/triggering devices

4.3.3.1.    Market size, by region, 2013-2024 (USD Million)

4.3.4.  Identifiers

4.3.4.1.    Market size, by region, 2013-2024 (USD Million)

4.3.5.  Assays and reagents

4.3.5.1.    Market size, by region, 2013-2024 (USD Million)

Chapter 5. Biodefense Market, By Region

5.1. Key regional trends

5.2. North America

5.2.1.  Market size, by country, 2013 - 2024 (USD Million)

5.2.2.  Market size, by product, 2013 - 2024 (USD Million)

5.2.3.  U.S.

5.2.3.1.    Market size, by product, 2013 – 2024 (USD Million)

5.2.4.  Canada

5.2.4.1.    Market size, by product, 2013 – 2024 (USD Million)

5.3. Europe

5.3.1.  Market size, by country, 2013 - 2024 (USD Million)

5.3.2.  Market size, by product, 2013 - 2024 (USD Million)

5.3.3.  Germany

5.3.3.1.    Market size, by product, 2013 – 2024 (USD Million)

5.3.4.  France

5.3.4.1.    Market size, by product, 2013 – 2024 (USD Million)

5.3.5.  UK

5.3.5.1.    Market size, by product, 2013 – 2024 (USD Million)

5.3.6.  Italy

5.3.6.1.    Market size, by product, 2013 – 2024 (USD Million)

5.3.7.   Spain

5.3.7.1.    Market size, by product, 2013 – 2024 (USD Million)

5.4. Asia Pacific

5.4.1.  Market size, by country, 2013 - 2024 (USD Million)

5.4.2.  Market size, by product, 2013 - 2024 (USD Million)

5.4.3.  China

5.4.3.1.    Market size, by product, 2013 – 2024 (USD Million)

5.4.4.  Japan

5.4.4.1.    Market size, by product, 2013 – 2024 (USD Million)

5.4.5.  India

5.4.5.1.    Market size, by product, 2013 – 2024 (USD Million)

5.4.6.  Australia

5.4.6.1.    Market size, by product, 2013 – 2024 (USD Million)

5.4.7.  South Korea

5.4.7.1.    Market size, by product, 2013 – 2024 (USD Million)

5.5. Latin America

5.5.1.  Market size, by country, 2013 - 2024 (USD Million)

5.5.2.  Market size, by product, 2013 - 2024 (USD Million)

5.5.3.  Brazil

5.5.3.1.    Market size, by product, 2013 – 2024 (USD Million)

5.5.4. Mexico

5.5.4.1.    Market size, by product, 2013 – 2024 (USD Million)

5.5.5. Argentina

5.5.5.1.    Market size, by product, 2013 – 2024 (USD Million)

5.6. MEA

5.6.1.  Market size, by country, 2013 - 2024 (USD Million)

5.6.2.  Market size, by product, 2013 - 2024 (USD Million)

5.6.3.  South Africa

5.6.3.1.    Market size, by product, 2013 – 2024 (USD Million)

5.6.4.  Saudi Arabia

5.6.4.1.    Market size, by product, 2013 – 2024 (USD Million)

5.6.5.  UAE

5.6.5.1.    Market size, by product, 2013 – 2024 (USD Million)

5.6.6.  Israel

5.6.6.1.    Market size, by product, 2013 – 2024 (USD Million)

Chapter 6. Company Profiles

6.1.   Achaogen

6.1.1.  Business overview

6.1.2.  Financial data

6.1.3.  Product landscape

6.1.4.  Strategic outlook

6.1.5.  SWOT analysis

6.2.   Alnylam Pharmaceuticals

6.2.1.  Business overview

6.2.2.  Financial data

6.2.3.  Product landscape

6.2.4.  Strategic outlook

6.2.5.  SWOT analysis

6.3.   Altimmune

6.3.1.  Business overview

6.3.2.  Financial data

6.3.3.  Product landscape

6.3.4.  Strategic outlook

6.3.5.  SWOT analysis

6.4.   AISense

6.4.1.  Business overview

6.4.2.  Financial data

6.4.3.  Product landscape

6.4.4.  Strategic outlook

6.4.5.  SWOT analysis

6.5.   Alexeter Technologies, LLC

6.5.1.  Business overview

6.5.2.  Financial data

6.5.3.  Product landscape

6.5.4.  Strategic outlook

6.5.5.  SWOT analysis

6.6.   ANP Technologies

6.6.1.  Business overview

6.6.2.  Financial data

6.6.3.  Product landscape

6.6.4.  Strategic outlook

6.6.5.  SWOT analysis

6.7.   Bavarian Nordic

6.7.1.  Business overview

6.7.2.  Financial data

6.7.3.  Product landscape

6.7.4.  Strategic outlook

6.7.5.  SWOT analysis

6.8.   BBI Detection

6.8.1.  Business overview

6.8.2.  Financial data

6.8.3.  Product landscape

6.8.4.  Strategic outlook

6.8.5.  SWOT analysis

6.9.   Cleveland BioLabs, Inc.

6.9.1.  Business overview

6.9.2.  Financial data

6.9.3.  Product landscape

6.9.4.  Strategic outlook

6.9.5.  SWOT analysis

6.10.  Dynavax Technologies, Inc.

6.10.1.    Business overview

6.10.2.    Financial data

6.10.3.    Product landscape

6.10.4.    Strategic outlook

6.10.5.    SWOT analysis

6.11.  DynPort Vaccine Company LLC

6.11.1.    Business overview

6.11.2.    Financial data

6.11.3.    Product landscape

6.11.4.    Strategic outlook

6.11.5.    SWOT analysis

6.12.  Elusys Therapeutics

6.12.1.    Business overview

6.12.2.    Financial data

6.12.3.    Product landscape

6.12.4.    Strategic outlook

6.12.5.    SWOT analysis

6.13.  Emergent BioSolutions

6.13.1.    Business overview

6.13.2.    Financial data

6.13.3.    Product landscape

6.13.4.    Strategic outlook

6.13.5.    SWOT analysis

6.14.  Ichor Medical Systems, Inc.

6.14.1.    Business overview

6.14.2.    Financial data

6.14.3.    Product landscape

6.14.4.    Strategic outlook

6.14.5.    SWOT analysis

6.15.  Nanotherapeutics Inc.

6.15.1.    Business overview

6.15.2.    Financial data

6.15.3.    Product landscape

6.15.4.    Strategic outlook

6.15.5. SWOT analysis

6.16.  New Horizons Diagnostics

6.16.1.    Business overview

6.16.2.    Financial data

6.16.3.    Product landscape

6.16.4.    Strategic outlook

6.16.5.    SWOT analysis

6.17.  PathSensors

6.17.1.    Business overview

6.17.2.    Financial data

6.17.3.    Product landscape

6.17.4.    Strategic outlook

6.17.5.    SWOT analysis

6.18.  Research International

6.18.1.    Business overview

6.18.2.    Financial data

6.18.3.    Product landscape

6.18.4.    Strategic outlook

6.18.5.    SWOT analysis

6.19.  SIGA Technologies

6.19.1.    Business overview

6.19.2.    Financial data

6.19.3.    Product landscape

6.19.4.    Strategic outlook

6.19.5.    SWOT analysis

 

Data Tables

TABLE 1.    Biodefense industry 360° synopsis, 2013 – 2024

TABLE 2.    Biodefense market, 2013-2024 (USD Mn)

TABLE 3.    Biodefense market, by product, 2013-2024 (USD Mn)

TABLE 4.    Biodefense market, by application, 2013-2024 (USD Mn)

TABLE 5.    Biodefense market, by end-user 2013-2024 (USD Mn)

TABLE 6.    Biodefense market, by region, 2013-2024 (USD Mn)

TABLE 7.    Industry impact forces

TABLE 8.    Vaccines market size, by region, 2013-2024 (USD Mn)

TABLE 9.    Anthrax market size, by region, 2013-2024 (USD Mn)

TABLE 10.    Smallpox market size, by region, 2013-2024 (USD Mn)

TABLE 11.    Botulism market size, by region, 2013-2024 (USD Mn)

TABLE 12.    Others market size, by region, 2013-2024 (USD Mn)

TABLE 13.    Biothreat detection devices market size, by region, 2013-2024 (USD Mn)

TABLE 14.    Samplers market size, by region, 2013-2024 (USD Mn)

TABLE 15.    Detectors/triggering devices market size, by region, 2013-2024 (USD Mn)

TABLE 16.    Identifiers market size, by region, 2013-2024 (USD Mn)

TABLE 17.    Assays and reagents market size, by region, 2013-2024 (USD Mn)

TABLE 18.    North America biodefense market size, by country, 2013-2024 (USD Mn)

TABLE 19.    North America biodefense market size, by product, 2013-2024 (USD Mn)

TABLE 20.    U.S. biodefense market size, by product, 2013-2024 (USD Mn)

TABLE 21.    Canada biodefense market size, by product, 2013-2024 (USD Mn)

TABLE 22.    Europe biodefense market size, by country, 2013-2024 (USD Mn)

TABLE 23.    Europe biodefense market size, by product, 2013-2024 (USD Mn)

TABLE 24.    Germany biodefense market size, by product, 2013-2024 (USD Mn)

TABLE 25.    UK biodefense market size, by product, 2013-2024 (USD Mn)

TABLE 26.    France biodefense market size, by product, 2013-2024 (USD Mn)

TABLE 27.    Spain biodefense market size, by product, 2013-2024 (USD Mn)

TABLE 28.    Italy biodefense market size, by product, 2013-2024 (USD Mn)

TABLE 29.    Asia Pacific biodefense market size, by country, 2013-2024 (USD Mn)

TABLE 30.    Asia Pacific biodefense market size, by product, 2013-2024 (USD Mn)

TABLE 31.    Japan biodefense market size, by product, 2013-2024 (USD Mn)

TABLE 32.    China biodefense market size, by product, 2013-2024 (USD Mn)

TABLE 33.    India biodefense market size, by product, 2013-2024 (USD Mn)

TABLE 34.    Australia biodefense market size, by product, 2013-2024 (USD Mn)

TABLE 35.    South Korea biodefense market size, by product, 2013-2024 (USD Mn)

TABLE 36.    Latin America biodefense market size, by country, 2013-2024 (USD Mn)

TABLE 37.    Latin America biodefense market size, by product, 2013-2024 (USD Mn)

TABLE 38.    Brazil biodefense market size, by product, 2013-2024 (USD Mn)

TABLE 39.    Mexico biodefense market size, by product, 2013-2024 (USD Mn)

TABLE 40.    Argentina biodefense market size, by product, 2013-2024 (USD Mn)

TABLE 41.    MEA biodefense market size, by country, 2013-2024 (USD Mn)

TABLE 42.    MEA biodefense market size, by product, 2013-2024 (USD Mn)

TABLE 43.    South Africa biodefense market size, by product, 2013-2024 (USD Mn)

TABLE 44.    Saudi Arabia biodefense market size, by product, 2013-2024 (USD Mn)

TABLE 45.    UAE biodefense market size, by product, 2013-2024 (USD Mn)

TABLE 46.    Israel biodefense market size, by product, 2013-2024 (USD Mn)

Charts & Figures

FIG 1. Industry segmentation

FIG 2. Global biodefense market, 2013 - 2024 (USD Mn)

FIG 3. Growth potential analysis, by product

FIG 4. Porter’s analysis

FIG 5. Strategy dashboard

FIG 6. PESTEL analysis

Premium Report Details

  • Published Date: Jan 2019
  • Pages: 115
  • Tables: 44
  • Charts / Figures: 6
  • Companies covered: 16
  • Countries covered: 17

Get a report that explains COVID-19 impact on this market

Buy NowImmediate delivery available

Need a Discount? Get in touch with us for special pricing

Request Discount

 Connect with our sales team

Chat with us
We use cookies to enhance user experience. (Privacy Policy) X